New York University

New York, New York
Private University
Founded 1831

New York University is a private research university anchored around Washington Square in Greenwich Village, with a $1.5 billion research enterprise and one of the most commercially productive tech-transfer track records in U.S. academia, most famously the Remicade antibody franchise.

$1.5B
R&D (FY2024)
41
US Patents (2025)
373
Disclosures (FY2024)
103
Licenses (FY2024)
19
Startups (FY2024)
$11.5M
License Revenue (FY2024)
$74.4M
Business-Funded R&D

Commercialization Approach

Technology Opportunities and Ventures translates the outputs of the university research base into commercial solutions and technologies to maximize their social and economic impact.

Research and Commercialization Data

Total R&D Expenditures

947108612241362150120202021202220232024
5-Year Change: 58.4%
Avg: 1249.0

Research Focus Areas

Biomedical & Translational Medicine

Clinical and therapeutic research driving the bulk of NYU commercialization

NYU Grossman School of MedicineNYU Langone HealthPerlmutter Cancer Center

Computer Science, AI & Mathematics

Foundational quantitative and computing research

Courant Institute of Mathematical SciencesCenter for Data ScienceTandon School of Engineering

Neuroscience & Precision Psychiatry

Brain and behavioral research feeding precision-psychiatry spinouts

NYU Neuroscience InstituteDepartment of Psychiatry

Related Market Maps

Explore market opportunities in deep tech categories relevant to NYU's research focus.

View all market maps →

Notable Spinouts

Ajax Therapeutics

Founded 2019 • Biotechnology

ACQUIRED

Structure-based precision therapies for myeloproliferative and blood disorders

$2.3B deal valueby Eli Lilly

Aethon Therapeutics

Biotechnology

ACTIVE

Custom antibody therapeutics with a novel approach to fighting cancer

Programs & Resources

NYU Entrepreneurial Institute

center

University-wide hub for startup education, venture support, and the Endless Frontier Labs accelerator

Learn more

Rankings & Recognition

#52National Academy of Inventors - US Utility Patents Granted
2025

Tech Transfer Office

NYU Technology Opportunities & Ventures (TOV)

Director: Marc Sedam

IP Portfolio Available

Life Sciences & TherapeuticsMedical DevicesDigital Health

Platform: e-lucid

Browse IP Portfolio

Services Offered

  • •Technology licensing
  • •Startup formation and venture support
  • •Corporate-sponsored research facilitation

Interested in Tech Transfer?

Learn how to navigate university licensing and commercialization